ANIP241220P45000
- 0.00
- 0.000.00%
ANI Pharmaceuticals Newsroom
Intrauterine Devices Market Report Forecasts and Company Analysis 2024-2032, Profiles of AbbVie, Bayer, Teva Pharmaceuticals, ANI Pharmaceuticals, Mylan, CooperSurgical. and DKT International
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?
ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference
Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect?
ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock?
ANI Pharmaceuticals Advances Amidst Regulatory and Market Challenges
Have ANI Pharmaceuticals Insiders Been Selling Stock?
Ani Pharmaceuticals Insider Sold Shares Worth $375,050, According to a Recent SEC Filing
US Manufacturing Index Rises To 43, Highest Since 2020
ANI Pharmaceuticals Price Target Maintained With a $94.00/Share by HC Wainwright & Co.
ANI Pharmaceuticals Analyst Ratings
Truist Financial Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating, Maintains Target Price $62
Truist Financial Remains a Hold on ANI Pharmaceuticals (ANIP)
H.C. Wainwright Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $94
ANI Pharmaceuticals: Buy Rating Backed by Consistent Revenue Growth, Strategic Acquisitions, and Strong Market Position
Express News | ANI Pharmaceuticals Inc : Piper Sandler Raises Target Price to $69 From $68
ANI Pharmaceuticals (NASDAQ:ANIP) Rallies 5.6% This Week, Taking Three-year Gains to 35%
ANI Pharmaceuticals, Inc. (ANIP) Q3 2024 Earnings Call Transcript Summary
ANI Pharmaceuticals' Record Growth and Strategic Acquisition
ANI Pharmaceuticals | 10-Q: Q3 2024 Earnings Report